These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 8768094)

  • 1. [Reason for the damping effect of tumor cells on human T-lymphocytes].
    Strelkov LA; Mikhaĭlova AA; Sapozhnikov AM; Petrov RV
    Dokl Akad Nauk; 1996 Mar; 347(2):278-80. PubMed ID: 8768094
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of sphingolipid synthesis down-modulates CD4 expression by peripheral blood T lymphocytes and T lymphoma cells.
    Tamma SL; Sundaram SK; Lev M; Coico RF
    Biochem Biophys Res Commun; 1996 Mar; 220(3):916-21. PubMed ID: 8607867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor requirements for activation and proliferation steps of human CD2+CD3-CD4-CD8- early thymocytes.
    Dalloul AH; Mossalayi MD; Dellagi K; Bertho JM; Debré P
    Eur J Immunol; 1989 Nov; 19(11):1985-90. PubMed ID: 2574677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD3 bright lymphocyte population reveal gammadelta T cells.
    Lambert C; Genin C
    Cytometry B Clin Cytom; 2004 Sep; 61(1):45-53. PubMed ID: 15351982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of CD7 in classical Hodgkin lymphoma-infiltrating T lymphocytes.
    Seegmiller AC; Karandikar NJ; Kroft SH; McKenna RW; Xu Y
    Cytometry B Clin Cytom; 2009 May; 76(3):169-74. PubMed ID: 18956470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.
    Woo EY; Chu CS; Goletz TJ; Schlienger K; Yeh H; Coukos G; Rubin SC; Kaiser LR; June CH
    Cancer Res; 2001 Jun; 61(12):4766-72. PubMed ID: 11406550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trypanosoma cruzi inhibits the expression of CD3, CD4, CD8, and IL-2R by mitogen-activated helper and cytotoxic human lymphocytes.
    Sztein MB; Cuna WR; Kierszenbaum F
    J Immunol; 1990 May; 144(9):3558-62. PubMed ID: 2139458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell malignancy in Richter's syndrome presenting as hyper IgM. Induction and characterization of a novel CD3+, CD4-, CD8+ T cell subset from phytohemagglutinin-stimulated patient's CD3+, CD4+, CD8+ leukemic T cells.
    Raziuddin S; Assaf HM; Teklu B
    Eur J Immunol; 1989 Mar; 19(3):469-74. PubMed ID: 2523311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased production of interleukin-6 by T lymphocytes from patients with multiple myeloma.
    Lapeña P; Prieto A; Garcia-Suarez J; Reyes E; San Miguel J; Jorda J; Alvarez-Mon M
    Exp Hematol; 1996 Jan; 24(1):26-30. PubMed ID: 8536788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Level of receptor complex molecule expression of human blood T-lymphocytes under conditions of their UV-irradiation].
    Artiukhov VG; Putintseva OV; Vdovina VA; Koltakov IA; Pashkov MV; Vasilenko DV
    Radiats Biol Radioecol; 2011; 51(2):258-63. PubMed ID: 21674954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of human T cells that coexpress CD4 and CD8 by an immunomodulatory protein produced by Actinobacillus actinomycetemcomitans.
    Shenker BJ; Vitale L; King C
    Cell Immunol; 1995 Aug; 164(1):36-46. PubMed ID: 7634351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alloreactivity of ex vivo-expanded T cells is correlated with expansion and CD4/CD8 ratio.
    Mercier-Letondal P; Montcuquet N; Sauce D; Certoux JM; Jeanningros S; Ferrand C; Bonyhadi M; Tiberghien P; Robinet E
    Cytotherapy; 2008; 10(3):275-88. PubMed ID: 18418773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polychromatic (eight-color) slide-based cytometry for the phenotyping of leukocyte, NK, and NKT subsets.
    Mittag A; Lenz D; Gerstner AO; Sack U; Steinbrecher M; Koksch M; Raffael A; Bocsi J; Tárnok A
    Cytometry A; 2005 Jun; 65(2):103-15. PubMed ID: 15830380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
    Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
    Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of interleukin 2 receptor beta chain in initiating anti-CD3 and interleukin 2-induced proliferation of human resting T cells.
    Moiré N; Calvo CF; Métivier D; Perrot JY; Vaquero C; Hatakeyama M; Senik A
    Eur J Immunol; 1990 Sep; 20(9):1981-7. PubMed ID: 2145171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphokine activated killer cells and interleukin-2 production in patients with cervical carcinoma.
    De AK; Jhaver KG; Kamat MR; Nadkarni JJ
    Neoplasma; 1991; 38(5):493-9. PubMed ID: 1835519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
    Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
    Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the cytolytic activity of CD4+ and CD8+ tumor-infiltrating lymphocytes in human renal cell carcinoma.
    Finke JH; Rayman P; Alexander J; Edinger M; Tubbs RR; Connelly R; Pontes E; Bukowski R
    Cancer Res; 1990 Apr; 50(8):2363-70. PubMed ID: 2107973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-stimulation of T cell proliferation by transforming growth factor-beta 1.
    Lee HM; Rich S
    J Immunol; 1991 Aug; 147(4):1127-33. PubMed ID: 1831218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular interactions in effector cell generation and tumor regression mediated by anti-CD3/interleukin 2-activated tumor-draining lymph node cells.
    Yoshizawa H; Chang AE; Shu SY
    Cancer Res; 1992 Mar; 52(5):1129-36. PubMed ID: 1531321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.